Akoya Biosciences Shares Jump on 2024 Outlook, Thermo Fisher Deal
Galapagos, Thermo Fisher to Collaborate on Expanding Manufacturing of Cancer Drug
Thermo Fisher Says It Has Halted Sales of DNA Technology in Tibet
Illumina to Sell Grail. It’s Giving Up on Its Biotech Antitrust Battle.
Thermo Fisher Sets New $4 Billion Stock Buyback
Thermo Fisher Scientific Authorizes $4 Billion Of Share Repurchases >TMO
Thermo Fisher, The Biggest Name In Medical Equipment, Just Made A 'Drastic' Guidance Cut — Again
Thermo Fisher Stock Sinks
Thermo Fisher's Sales Missed Forecasts. Its Stock Is Down on Different Bad News.
Stock Market News
Health Care Down on Rotation to Cyclical Sectors -- Health Care Roundup
Olink Holding Shares Soar on Takeover by Thermo Fisher
Thermo Fisher to Buy Sweden's Olink for $3.1 Billion
Thermo Fisher to Buy Olink in $3.1 Billion Deal
Cadence Design Thrusts Past A New Entry Point
Cadence Design Thrusts Past A New Entry Point
UnitedHealth Action Improves As Market Heads Into New Correction
M&A Can Pay Off, but It’s Far From a Sure Thing
Drug Developer Stocks Are Risky. Why a Picks-and-Shovels Approach Makes Sense.
Family of Henrietta Lacks, Whose Unique Cells Changed Science, Settles With Thermo Fisher
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.